Halozyme Therapeutics, Inc. Common Stock (HALO)
Halozyme Therapeutics, Inc. Common Stock (HALO) has reported earnings 20 times since Aug 09, 2021. The stock moves an average of ±6.35% the day after reporting, closing higher 85.0% of the time. Its largest post-earnings gain was +20.08% (Aug 06, 2026) and its largest decline was -9.12% (Feb 17, 2026). The next earnings report is predicted for 2026-10-12 (estimated).
Earnings reactions
How HALO moved on each past earnings report.
Earnings Impact
Total Earnings
20
Avg Abs. Movement
±6.35%
Positive %
85.0%
Negative %
15.0%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Aug 06, 2026 | ☽ POST | +20.08% | open_in_new |
| May 11, 2026 | ☽ POST | +6.78% | open_in_new |
| Feb 17, 2026 | ☽ POST | -9.12% | open_in_new |
| Nov 03, 2025 | ☽ POST | +2.72% | open_in_new |
Earnings Count
20
Total earnings in dataset
Avg Abs. Movement
±6.35%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260902 | open_in_new SEC.gov |
| 3 | 20260821 | open_in_new SEC.gov |
| 4 | 20260819 | open_in_new SEC.gov |
| 8-K | 20260818 | open_in_new SEC.gov |
| 144 | 20260817 | open_in_new SEC.gov |
| 144 | 20260811 | open_in_new SEC.gov |
| 4 | 20260811 | open_in_new SEC.gov |
| 144 | 20260810 | open_in_new SEC.gov |
| 10-Q | 20260806 | open_in_new SEC.gov |
| 8-K | 20260806 | open_in_new SEC.gov |
Frequently asked about HALO earnings
When does Halozyme Therapeutics, Inc. Common Stock report earnings next? expand_more
Halozyme Therapeutics, Inc. Common Stock (HALO)'s next earnings date is estimated for 2026-10-12. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does HALO stock move after earnings? expand_more
Over 20 reports, HALO has moved an average of ±6.35% the session after earnings, closing higher 85.0% of the time.
What was HALO's biggest post-earnings move? expand_more
HALO's largest post-earnings gain on record was +20.08% on Aug 06, 2026, and its largest decline was -9.12% on Feb 17, 2026.
Where can I find Halozyme Therapeutics, Inc. Common Stock's SEC filings? expand_more
All of Halozyme Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right